Vaxxinity is a biotechnology company that develops a platform for therapeutics delivery. The Vaxxine Platform uses synthetic peptides to mimic and combine biological epitopes to selectively activate the immune system, producing antibodies against targets, including self-antigens. Its product candidates include UB-311, UB-312, Tau, UB-313, PCSK9, and UB-612 for the treatment of Alzheimer’s and Parkinson’s diseases, Migraines, Hypercholesterolemia, and Covid-19.